A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 1, 2010, Pages 115-121

  Orphanos, George ^a,b   Alexopoulos, Athanasios ^a   Malliou, Savvoula ^a   Ioannidis, George ^a   Ardavanis, Alexandros ^a   Kandylis, Constantinos ^a   Stavrakakis, John ^a   Rigatos, Gerassimos ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b Ygia Polyclinic ^*  (Cyprus)

Author keywords

Anthracyclines; Capecitabine; Chemotherapy; Metastatic breast cancer; Taxanes; Vinorelbine

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FEMALE; GRANULOCYTOPENIA; HAND FOOT SYNDROME; HUMAN; LIVER TOXICITY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; AGED; ANEMIA; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NAUSEA; NEOPLASM METASTASIS; NEUTROPENIA; TAXOIDS; TREATMENT OUTCOME; VINBLASTINE; VOMITING;

EID: 71449085927     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0642-0     Document Type: Article

References (49)

1. DL Ahmann DJ Schaid HF Bisel, et al. 1987 The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug J Clin Oncol 5 12 1928 1932 3316516
2. E Bajetta G Procopio L Celio, et al. 2005 Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women J Clin Oncol 23 10 2155 2161 10.1200/JCO.2005.02.167 10.1200/JCO.2005.02.167 15710946 (Pubitemid 46218707)
3. C Bernard-Marty F Cardoso MJ Piccart 2004 Facts and controversies in systemic treatment of metastatic breast cancer Oncologist 9 6 617 632 10.1634/theoncologist.9-6-617 10.1634/theoncologist.9-6-617 15561806 (Pubitemid 39546403)
4. A Berruti P Sperone A Bottini, et al. 2000 Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines J Clin Oncol 18 19 3370 3377 11013277
5. JL Blum SE Jones AU Buzdar, et al. 1999 Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer J Clin Oncol 17 2 485 493 10080589
6. JL Blum V Dieras PM Lo Russo, et al. 2001 Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients Cancer 92 7 1759 1768 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A 11745247 (Pubitemid 32952493)
7. S Bruno VL Puerto E Mickiewicz, et al. 1995 Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience Am J Clin Oncol 18 5 392 396 7572754
8. D Cunningham R Coleman 2001 New options for outpatient chemotherapy-the role of oral fluoropyrimidines Cancer Treat Rev 27 4 211 220 10.1053/ctrv.2001.0229 10.1053/ctrv.2001.0229 11545541 (Pubitemid 32851175)
9. Davidson NG (1996) Single-agent paclitaxel as first-line treatment of metastatic breast cancer: the British experience. Semin Oncol 23(5) (Suppl 11):6-10
10. V Dieras JM Extra E Bellissant, et al. 1996 Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method J Clin Oncol 14 12 3097 3104 8955654
11. B Fazeny U Zifko S Meryn, et al. 1996 Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel-a phase II study Cancer Chemother Pharmacol 39 1-2 150 156 10.1007/s002800050551 10.1007/s002800050551 8995513 (Pubitemid 26400674)
12. M Findlay G von Minckwitz A Wardley 2008 Effective oral chemotherapy for breast cancer: pillars of strength Ann Oncol 19 2 212 222 10.1093/annonc/mdm285 10.1093/annonc/mdm285 18006898 (Pubitemid 351201700)
13. P Fumoleau FM Delgado T Delozier, et al. 1993 Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy J Clin Oncol 11 7 1245 1252 8315421
14. P Fumoleau JL Blum P Reichardt 2003 Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma Cancer 98 6 1325 1326 10.1002/cncr.11577 10.1002/cncr.11577 12973858 (author reply 1326-1327) (Pubitemid 37099919)
15. P Fumoleau R Largillier C Clippe, et al. 2004 Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer Eur J Cancer 40 4 536 542 10.1016/j.ejca.2003.11.007 10.1016/j.ejca.2003.11.007 14962720 (Pubitemid 38220770)
16. CE Geyer J Forster D Lindquist, et al. 2006 Lapatinib plus capecitabine for HER2-positive advanced breast cancer N Engl J Med 355 26 2733 2743 10.1056/NEJMoa064320 10.1056/NEJMoa064320 17192538 (Pubitemid 46021510)
17. M Ghosn J Kattan F Farhat, et al. 2008 Sequential vinorelbine- capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial Cancer Chemother Pharmacol 62 1 11 18 10.1007/s00280-007-0565-x 10.1007/s00280-007-0565-x 17717668
18. D Hess B Thurlimann O Pagani, et al. 2004 Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99) Ann Oncol 15 12 1760 1765 10.1093/annonc/mdh467 10.1093/annonc/mdh467 15550580 (Pubitemid 40012242)
19. GN Hortobagyi HY Yap SW Kau, et al. 1989 A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer Am J Clin Oncol 12 1 57 62 10.1097/00000421-198902000-00014 10.1097/00000421-198902000- 00014 2643296
20. A Jakob C Bokemeyer S Knop, et al. 2002 Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation-a phase II study Anticancer Drugs 13 4 405 410 10.1097/00001813-200204000-00009 10.1097/00001813-200204000-00009 11984086 (Pubitemid 34454726)
21. C Jara-Sanchez M Martin JA Garcia-Saenz, et al. 2003 Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group Clin Breast Cancer 3 6 399 404 10.3816/CBC.2003.n.004 10.3816/CBC.2003.n.004 12636884
22. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 2 71 96 10.3322/CA.2007.0010 10.3322/CA.2007.0010 18287387
23. SH Lee J Lee J Park, et al. 2004 Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer Med Oncol 21 3 223 231 10.1385/MO:21:3:223 10.1385/MO:21:3:223 15456949 (Pubitemid 39469762)
24. RB Livingston GK Ellis JR Gralow, et al. 1997 Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer J Clin Oncol 15 4 1395 1400 9193331
25. WT Loo H Sasano LW Chow 2007 Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues Biomed Pharmacother 61 9 596 600 10.1016/j.biopha.2007.08.022 10.1016/j.biopha.2007.08.022 17904787 (Pubitemid 47570082)
26. J Mackey A Paterson LY Dirix 2002 Final results of the phase III randomized trial comparing docetaxel (T), doxorubicin (A) and cyclophosphamide (C) to FAC as first line chemotherapy (CT) for patients (pts) with metastatic breast cancer (MBC) Proc Am Soc Clin Oncol 35 137
27. G Mariani 2005 New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy Ann Oncol 16 Suppl 2 ii191 ii194 10.1093/annonc/mdi719 10.1093/annonc/mdi719 15958455 (Pubitemid 40908955)
28. KD Miller LI Chap FA Holmes, et al. 2005 Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer J Clin Oncol 23 4 792 799 10.1200/JCO.2005.05.098 10.1200/JCO.2005.05.098 15681523 (Pubitemid 46224178)
29. F Nole F de Braud M Aapro, et al. 1997 Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden Ann Oncol 8 9 865 870 10.1023/A:1008209429204 10.1023/A:1008209429204 9358936 (Pubitemid 27452083)
30. J O'Shaughnessy D Miles S Vukelja, et al. 2002 Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results J Clin Oncol 20 12 2812 2823 10.1200/JCO.2002.09.002 10.1200/JCO.2002.09.002 12065558 (Pubitemid 34651510)
31. MM Oken RH Creech DC Tormey, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 6 649 655 10.1097/00000421-198212000-00014 10.1097/00000421-198212000-00014 7165009
32. JA Oshaughnessy J Blum V Moiseyenko, et al. 2001 Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer Ann Oncol 12 9 1247 1254 10.1023/A:1012281104865 10.1023/A:1012281104865 11697835 (Pubitemid 32994752)
33. B Pajk T Cufer P Canney, et al. 2008 Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial Breast 17 2 180 185 10.1016/j.breast.2007.09.002 10.1016/j.breast.2007.09.002 17976988
34. R Paridaens L Biganzoli P Bruning, et al. 2000 Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over J Clin Oncol 18 4 724 733 10673513
35. JO Park SI Lee SY Song, et al. 2003 Measuring response in solid tumors: comparison of RECIST and WHO response criteria Jpn J Clin Oncol 33 10 533 537 10.1093/jjco/hyg093 10.1093/jjco/hyg093 14623923 (Pubitemid 43115248)
36. P Reichardt G Von Minckwitz PC Thuss-Patience, et al. 2003 Multicenter phase II study of oral capecitabine (Xeloda(″)) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy Ann Oncol 14 8 1227 1233 10.1093/annonc/mdg346 10.1093/annonc/mdg346 12881384 (Pubitemid 37039048)
37. A Romero MG Rabinovich CT Vallejo, et al. 1994 Vinorelbine as first-line chemotherapy for metastatic breast carcinoma J Clin Oncol 12 2 336 341 8113840
38. AF Schott JM Rae KA Griffith, et al. 2006 Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme Cancer Chemother Pharmacol 58 1 129 135 10.1007/s00280-005-0132-2 10.1007/s00280-005-0132-2 16283312
39. AD Seidman BS Reichman JP Crown, et al. 1995 Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response J Clin Oncol 13 5 1152 1159 7537798
40. AD Seidman CA Hudis J Albanell, et al. 1998 Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer J Clin Oncol 16 10 3353 3361 9779712
41. GW Sledge D Neuberg P Bernardo, et al. 2003 Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193) J Clin Oncol 21 4 588 592 10.1200/JCO.2003.08.013 10.1200/JCO.2003.08. 013 12586793 (Pubitemid 46621890)
42. R Sorio I Robieux E Galligioni, et al. 1997 Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer Eur J Cancer 33 2 301 303 10.1016/S0959-8049(96)00426-1 10.1016/S0959-8049(96)00426-1 9135505 (Pubitemid 27117731)
43. DC Talbot V Moiseyenko S Van Belle, et al. 2002 Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines Br J Cancer 86 9 1367 1372 10.1038/sj.bjc.6600261 10.1038/sj.bjc.6600261 11986765 (Pubitemid 34548055)
44. DI Udom DM Vigushin H Linardou, et al. 2000 Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer Eur J Cancer 36 2 177 182 10.1016/S0959-8049(99)00219-1 10.1016/S0959-8049(99)00219-1 10741275 (Pubitemid 30102193)
45. S Verma NS Wong M Trudeau, et al. 2007 Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane Am J Clin Oncol 30 3 297 302 10.1097/01.coc.0000258125.97090.3f 10.1097/01.coc.0000258125.97090.3f 17551309 (Pubitemid 46884152)
46. C Vogel M O'Rourke E Winer, et al. 1999 Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older Ann Oncol 10 4 397 402 10.1023/A:1008364222793 10.1023/A:1008364222793 10370781 (Pubitemid 29236416)
47. BL Weber C Vogel S Jones, et al. 1995 Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer J Clin Oncol 13 11 2722 2730 7595730
48. A Welt G von Minckwitz C Oberhoff, et al. 2005 Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer Ann Oncol 16 1 64 69 10.1093/annonc/mdi024 10.1093/annonc/mdi024 15598940 (Pubitemid 40124480)
49. L Zelek S Barthier M Riofrio, et al. 2001 Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma Cancer 92 9 2267 2272 10.1002/1097-0142(20011101)92: 9<2267::AID-CNCR1572>3.0.CO;2-Q 10.1002/1097-0142(20011101)92:9<2267:: AID-CNCR1572>3.0.CO;2-Q 11745280 (Pubitemid 33029069)